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Abstract
BACKGROUND: The incidence of acute myocardial infarction (AMI) is increasing worldwide. Inflammation plays 
an essential role in the initiation and progression of atherosclerosis and the pathogenesis of acute cardiovascular 
events. C-reactive protein (CRP) has been shown to have prognostic value in patients with acute coronary syndrome, 
but the most promising use of CRP has been used for primary use. 
AIM: This study was aimed to explore the sensitivity of high-sensitivity CRP (hs-CRP) in assessing troponin T in AMI.
METHODS: The study design was an observational study to assess the sensitivity and specificity of hsCRP 
against troponin T in patients with AMI with ST-elevation and without ST-elevation. This research was conducted in 
Palembang, Indonesia. The study subjects were 56 patients with an acute myocardial infusion that met the inclusion 
and exclusion criteria.
RESULTS: The sensitivity of hs-CRP to troponin-T is 93.7%. The specificity of hs-CRP to troponin T was 37.5%. 
The positive suspected value is 0.9, the estimated negative value is 0.5, the positive likelihood ratio is 1.49, and the 
negative likelihood ratio is 0.16.
CONCLUSION: hs-CRP is quite sensitive in assessing troponin-T but not specific enough in assessing troponin-T 
activity.
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Introduction
Acute myocardial infarction (AMI) or 
better known as coronary heart disease (CHD) is 
a condition of heart muscle cell death caused by a 
sudden blockage in the coronary arteries that cause 
the decreasing blood supply to muscles. Blockages 
will be followed by thrombosis, vasoconstriction, 
inflammatory reactions, and distal microemboli. AMI 
can cause sudden death in sufferers. CHD is the 
number one cause of death in Europe and America 
as well as in Indonesia, both for men and women. The 
morbidity and mortality rate of CHD in Indonesia has 
increased sharply in the past 20 years, as seen in the 
Indonesian Family Health Survey. The survey in 1996 
showed that the cause of the disease increased from 
year to year as a cause of death. In 1975, deaths from 
heart disease were only 5.9%, in 1981, it increased 
to 9.1%, in 1986, it jumped to 16%, and in 1995, it 
increased to 19%. The 2001 national census causing 
death due to cardiovascular disease, including CHD, 
was 26.4%. In 2013, ±478,000 patients in Indonesia 
were diagnosed with CHD at this time, the prevalence 
of ST-elevation myocardial infarction (STEMI) 
increased from 25% to 40% of all presentations 
incidence of myocardial infarction [1-5].
In recent years, the incidence of AMI is 
increasing worldwide in developing countries. 
Inflammation plays an essential role in the initiation and 
progression of atherosclerosis and the pathogenesis of 
acute cardiovascular events. Inflammation also plays a 
role in the development of atherosclerosis and CHD. 
The most common cause is that CHD is atherosclerosis 
with erosion or plaque rupture, which causes a transient 
blockage, partially or totally from arteries. Several risk 
factors are considered for atherosclerosis which is 
a significant cause of AMI such as obesity, diabetes, 
stress, smoking, hypertension, hyperlipidemia, and 
chronic inflammation due to infection [6]. Troponin-T 
is the gold standard method for the detection of AMI. 
A prolonged increase after AMI obscures the increase 
in AMI and return infarction besides troponin also 
has limitations in terms of the price of troponin-T 
examination, the ability to survive reagents, and support 
the examination material in the hospital [1,2].
The efforts to look for markers of CHD began 
in the 19th century. More than 60% of patients who 
experience coronary heart problems have only one 
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without traditional risk factors and more than half of 
patients who have average or slightly increased lipid 
levels. One of the biomarkers that have been owned 
estimated as an indicator of the inflammatory process 
in cardiovascular disorders is C-reactive protein (CRP). 
CRP has been shown to have prognostic value in 
patients with the acute coronary syndrome, but the 
most promising use of CRP has been used for primary 
use. CRP can not only be a marker of critical grade 
systemic inflammation but can also be directly involved 
in atherosclerosis [7-11]. In addition to CRP as an 
inflammatory factor, some studies show serum uric acid 
levels produced as a determining factor for coronary 
artery disease and congestive heart failure [12]. 
Conventional CRP measurements are only adequate for 
monitoring severe inflammatory conditions but cannot 
measure accurately for cardiovascular risk protection. 
Therefore, a more sensitive CRP measurement method 
is needed to measure CRP increase at lower levels. 
Routine serum CRP examination (immunonephelometry 
method) cannot measure CRP levels of more than 
3 mg/L. These values are average according to 
conventional tests, although several studies have 
shown that at CRP <3 mg/L and are a predisposition for 
atherothrombosis [13]. A high-sensitivity test for CRP is 
called high-sensitivity CRP (hs-CRP) as an examination 
to obtain CRP findings that are so small that it is more 
sensitive to the measurement range between 0.1 and 
20 mg/L [14]. According to this fact, this research was 
aimed to explore the sensitivity of hs-CRP in AMI.
Methods
The study design was a diagnostic test to assess 
the sensitivity and specificity of hs-CRP against troponin 
T in patients with AMI with ST-elevation and without 
ST-elevation. This research was conducted at Dr. Moh 
Hoesin General Hospital, Palembang, Indonesia. The 
study subjects were 56 patients with an AMI that met 
the inclusion and exclusion criteria. Inclusion criteria 
were all patients with AMI (STEMI and NSTEMI) who 
were confirmed based on WHO criteria, namely, typical 
chest pain complaints, electrocardiography (ECG) 
examination, and troponin T elevations and were willing 
to participate in the study by signing informed consent. 
Exclusion criteria were patients with comorbid diseases 
such as chronic infection, degenerative disorders, 
malignancies, and autoimmune disorders.
Myocardial infarction with ST or STEMI 
elevation is all patients when they arrive or are 
treated to meet WHO criteria where two out of three 
symptoms for chest pain complaints, ECG examination 
by researchers obtained a description of ST-segment 
elevation in two consecutive leads and ≥0.25 mV in 
men in under 40 years, ≥0.2 mV in men over 40 years, 
or ≥0.15 mV in women and an increase in cardiac 
enzymes. Myocardial infarction without ST or NSTEMI 
elevation is all patients when they arrive or are treated 
in compliance with the WHO criteria which were 2 of 3 
criteria for complaints of chest pain, ECG examination 
by researchers obtained depiction of ST-segment 
depression ≥1 mm, changes in T≥2 mm waves, and 
Q waves persistence accompanied by an increase in 
cardiac enzymes [8,9].
Serum hsCRP levels are taken from blood 
samples of patients with AMI. If hs-CRP level <1.0 mg/L, 
it means low risk of cardiovascular disease, hs-CRP 
1.0–3.0 mg/L: Moderate risk of cardiovascular disease 
(intermediate risk) and hs-CRP>3.0 mg/L (<10 mg/L): 
High risk of cardiovascular disease. High levels of 
troponin-T are serum troponin-T levels taken from 
blood samples of patients with AMI. Troponin-T levels 
are low when ≤100 ng/L and troponin-T levels are high 
when > 100 ng/L [10].
All data obtained from this study were 
analyzed using the SPSS version 22.0 for windows 
program with a 95% confidence limit. Descriptive 
data analysis of categorical variables is presented in 
numbers and proportions. Descriptive data analysis 
of numerical variables with normal distribution is 
presented in the form of mean ± standard deviation, 
analysis of numerical descriptive data with abnormal 
distribution in the form of the median (minimum 
value–maximum value). Assessing data with normal 
distribution or abnormal distribution can be descriptive 
with variance or analytical coefficient with Shapiro–
Wilk. Analysis of normally distributed data using 
unpaired t-test, whereas if the data are not generally 
distributed with Mann–Whitney U test. Statistical tests 
to prove the diagnostic value of uric acid and serum 
CRP for diagnosing AMI include several quantities 
such as sensitivity, specificity, positive suspected 
value, negative predictive value, positive likelihood 
ratio, and negative likelihood ratio.
Results
Table 1 of the 56 study subjects found the 
highest frequency in men as many as 42 subjects 
(75%). The age of the patients in this study varied with 
an average age of 58.68 ± 9.16 years. The educational 
background of the subjects of this study ranging from 
the most to the lowest in a row was senior high school 
as many as 39 subjects (69.6%). The types of jobs were 
obtained by 12 civil servants (21.4%).
Table 2 is a cross-tabulation between hs-CRP 
and troponin-T levels. Based on Table 2, it is found that 
the sensitivity of hs-CRP to Troponin T is 93.7%. The 
specificity of hs-CRP to troponin-T was 37.5%. The 
positive suspected value is 0.9, the estimated negative 
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value is 0.5, the positive likelihood ratio is 1.49, and the 
negative likelihood ratio is 0.16.
Table 2: hs-CRP versus troponin-T diagnostic test
Variable Troponin-T level Total
>100 ng/l ≤100 ng/l
hs-CRP level ≥3 mg/dl 45 5 50
<3 mg/dl 3 3 6
Amount 48 8 56
hs-CRP levels of CRP ≥3 mg/dL is high risk, <3 mg/dL is intermediate and low risk; troponin-t >100 ng /L is 
high; ≤100 ng /L is low. hs-CRP: High-sensitivity C-reactive protein
Discussion
Increased troponin-T occurs due to damage to 
the heart muscle myocyte cells. Troponin will increase 
in blood after 3 h after infarction and last for 14 days. 
Troponin-T has a higher sensitivity and specificity than 
the creatine kinase-myocardial band [15,16]. In STEMI, 
a broader atherosclerotic plaque rupture will be followed 
by an acute thrombosis in the blood vessel lumen, 
potentially causing total occlusion of the coronary artery 
lumen, or infarct-related description of ST-elevation 
segment characterizes larger arteries on the ECG 
examination of the patient. In contrast, in NSTEMI, the 
rupture or plaque tear is smaller so that it only causes 
occultation difficulties. Following the ischemic cascade, 
the occurrence of an acute process of thrombosis 
when a decrease will follow total and absence of 
collateral in myocardial diastolic function followed by a 
decrease in systolic myocardial function, abnormalities 
of myocardial movement (wall motion abnormality) 
will be seen on imaging tests both echocardiography 
or nuclear examination or MRI. Then, the process of 
ischemia continues before an ECG abnormality will be 
seen in the form of ST-elevation followed by complaints 
of chest pain in patients with AMI [17-19]. If this process 
continues and no immediate revascularization will 
result in more extensive myocardial necrosis indicated 
by high plasma troponin levels [20].
hs-CRP is a marker of systemic inflammation 
that is quite sensitive to serum. In the condition of AMI, 
there is a blockage in the coronary arteries. This causes 
the condition ischemia of heart muscle cells that are 
plagued by coronary arteries that are blocked. Ischemia 
will cause hypoxia in the tissues and cells of various 
organs [20]. Hypoxia causes activation of multiple 
death receptors and inflammatory receptors to cause 
mitochondrial dysfunction. This condition causes the 
death of heart cells which lead to damage and rupture 
of myocardial cells. Continuation of this condition 
causes the rupture of myocardial muscle and troponin-T 
protein. This causes an increase in the activity of the 
inflammatory marker protein and hs-CRP [18,20]. This 
study shows that hs-CRP is sensitive enough to assess 
an increase in troponin-T but not specific enough to 
assess an increase in troponin-T. This is possible 
because the inflammatory process can take place 
at various locations, not only in the heart during the 
process of AMI. The limitation of this study is the small 
number of samples so that, in future studies, a larger 
number of participants is needed so that the results 
obtained will be more representative and reliable.
Conclusion
hs-CRP is quite sensitive in assessing 
troponin-T, but it is not specific enough in assessing 
troponin-T activity.
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